Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007
|
|
- Lionel Daniel
- 5 years ago
- Views:
Transcription
1 Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007
2 AGENDA Ramsay Financial Performance Pre Capio UK ( Ramsay UK ) Ramsay Financial Performance Including Ramsay UK Operational Highlights Pre Ramsay UK Ramsay UK Rationale, performance & growth strategy Growth Strategy Brownfields Financial Year 2008 Outlook 1
3 HALF YEAR OVERVIEW (PRE RAMSAY UK) Strong half-year result on like-for-like basis Half-year core EPS growth tracking towards full-year guidance for low double-digit growth Strong organic growth across the portfolio with the minimal remaining Affinity synergies achieved Greenslopes turnaround started, Hollywood still being stabilised Brownfields expansion program progressing well 2
4 FINANCIAL PERFORMANCE (PRE RAMSAY UK) Half Year ended 31 December $ m $ m % Inc. Continuing Operations Operating Revenue 1, , % EBITDA % EBIT % Core NPAT continuing operations % Core EPS continuing operations % Interim dividend fully franked % (Core NPAT - continuing operations and Core EPS continuing operations are before specific items, amortisation of intangibles and divested operations) 3
5 GROUP FINANCIAL PERFORMANCE (INCLUDING RAMSAY UK) Continuing Operations (including Ramsay UK) Half Year ended 31 December $ m $ m % Inc. Operating Revenue 1, , % EBITDA % EBIT % Core NPAT continuing operations % Core EPS continuing operations % Group Items NPAT divested operations (0.7) 0.1 Specific items and amortisation of intangibles (net of tax) (9.6) (1.3) Net Profit after Tax (7.0%) (Core NPAT - continuing operations is before specific items, amortisation of intangibles and divested operations) 4
6 Specific Items and Amortisation of Intangibles (net of tax) Half Year Ended 31 December Specific Items and Amortisation of Intangibles (Net of Tax) $ m $ m Ramsay (Pre UK) Write off of capitalised borrowing costs (refinancing) Project costs, restructuring and integration Amortisation of intangibles Ramsay UK Restructuring and Integration costs
7 INTERIM DIVIDEND UP 15.4 % Final Dividend Interim Dividend 6
8 EBIT GROWTH (PRE RAMSAY UK) Group EBIT up 11% for half year 7
9 REVENUE ANALYSIS (PRE RAMSAY UK) Strong EBIT growth in all states, except WA (marginally diluted by Hollywood) Veteran hospitals represent 17% of total revenue Veteran patients within these hospitals represent 50% of revenue * On an annualised running rate, Ramsay UK to form approx 25% of group revenues 8
10 CORE NET PROFIT GROWTH (PRE RAMSAY UK) Core NPAT up 13.2% for the half year Strong organic growth on a like-for-like basis 9
11 CORE EPS GROWTH (PRE RAMSAY UK) Core EPS up 13.5% Better than planned 10
12 COMMITTED DEBT FUNDING In November 2007 Ramsay signed a new underwritten senior debt facility agreement for A$1.535B and 290M. To refinance existing senior debt To fund the unspent balance of the $550M in brownfield capex To fund Capio UK acquisition To provide headroom for future growth opportunities Committed senior debt funding until November 2012 with predetermined interest margins (according to leverage grid) Ramsay is therefore not exposed to any refinancing risk for the next 5 years. 11
13 EFFECTIVE BALANCE SHEET MANAGEMENT Strong & consistent cash flow (generated in the private hospital industry) underwrites debt servicing Additionally Ramsay is very focussed on cash flow and working capital management High cash conversion rate (see cash conversion slide) Ramsay has a risk averse philosophy to interest rate exposure and hedges a significant amount of total interest payable Approximately 85 % of interest rate exposure is currently hedged for periods of 2-5 years Replacement capex spend aligned to depreciation charge 12
14 HIGH CASH CONVERSION Cash flow generation in the December 07 half year was consistent with profitability (EBITDA of $157M v gross operating cash flow of $145M) This is particularly pleasing given that cash flow had been adversely affected in earlier periods by the impact of the transition out of the DVA 13 contracts. These past shortfalls have largely been made up.
15 OPERATIONAL HIGHLIGHTS (PRE RAMSAY UK) Group EBIT up 11% on strong performance across portfolio Strong organic EBIT growth in all states except WA (marginally diluted by Hollywood) Hospital EBIT growth 9% Veterans hospitals improving Greenslopes turning around Hollywood still being stabilised Total admissions up 3.7% 14
16 OPERATIONAL HIGHLIGHTS (PRE RAMSAY UK) Cost containment continues across the portfolio resulting in improved margins Supply costs Economies of scale Group EBIT (ex. Ramsay UK) margin up to 10.7% from 10.3% 15
17 EBITDA GROWTH & POSITIVE MARGIN TRENDS (PRE RAMSAY UK) Group EBITDA up 10.8% for the half year Group EBITDA margin 13.6% vs 13.1% Hospital EBITDA margin 17.9% vs 17.7% excl. prosthesis Hospital EBIT margin 14.7% vs 14.5% excl. prosthesis 16
18 RAMSAY S REVENUE GROWTH PATH Capio UK Acq Affinity Group Acq. Apr 05 Benchmark Group Acq. Jul 04 Greenslopes Major Expansion Opened May 03 Hollywood Major Expansion Opened Jul 02 Alpha Group Acq. May 01 North Shore Private Hosp Opened Jul 98 RHC Listed Sep 97 Greenslopes Acq. Feb 95 Hollywood Acq. Jan 94 Financial Year ended 30 June Pro-forma 12-Mth Run Rate 17
19 RAMSAY UK - RATIONALE Huge opportunity due to changing landscape Ramsay UK well positioned to capitalise on market changes and capture outsourcing of National Health Service (NHS) to private sector A strong, stand-alone business, completed Nov 23, 2007 contributed 6 weeks to results Business underpinned by stable Private Medical Insurance (PMI) market 18
20 RAMSAY UK PROFILE 4th largest operator of private hospitals in the UK Diverse business and revenue source 22 private hospitals across England with 854 beds and 48 operating theatres 9 Independent Sector Treatment Centres (ISTCs) 2 neurological rehabilitation homes 22-apartment retirement village In-hospital pathology services Fixed & mobile radiology units Day surgery unit London-based ophthalmology unit 19
21 RAMSAY UK PERFORMANCE 9 Independent Sector Treatment Centres (ISTCs) All Ramsay UK ISTCs experienced volume growth in calendar 2007 Already seeing high levels of contract activity in 2008 Rising NHS activity encouraging Increasing number of spot contracts have been negotiated Choose & Book rising through improved marketing Number of NHS patients treated at Ramsay UK hospitals in calendar 2007 more than double
22 RAMSAY UK PERFORMANCE Integration process going well Government remains fully committed to Choose & Book initiative Official launch supported by new website enabling GPs to access all providers on equal footing (public and private hospitals) ISTC Wave II reduction in contracts not reflective of government commitment to the private sector 21
23 RAMSAY UK - GROWTH STRATEGY Well positioned to benefit from further government outsourcing in coming months Full patient choice to be officially launched in April 2008 but staged use of Choose & Book already in place and increasing Ramsay models forecast slow growth in patient choice. Current activity suggests models are conservative PMI stable, self pay increasing with improved marketing Additional capacity may be required Acquisition opportunities Classic Hospitals expensive Other opportunities will be investigated to enhance the value of Ramsay UK 22
24 GROWTH STRATEGY BROWNFIELDS Ramsay already committed $550M for improvements and capacity expansion Approx 25% spent Average construction profile 18 months All projects are tracking well Brownfield developments expected to deliver earnings growth towards the end of FY08 and beyond 23
25 ADDITIONAL BROWNFIELD OPPORTUNITIES Opportunities exist to create additional mega referral centres across the country Designed to attract increased referrals Mega referral centres at various stages of planning: Warringal (well developed) St George (progressing well) Westmead (well developed) Pindarra (master planning stage) 24
26 FY 2008 OUTLOOK Strong fundamentals of private hospital industry will continue to underpin Ramsay s growth prospects Private Health Insurance membership continues to grow Strong organic growth to continue Ramsay UK performing to expectations, cents/share dilutive in FY08 Ramsay UK expected to be Core EPS accretive in FY10 and beyond Including Ramsay UK, Ramsay is targeting low double-digit growth for the total group for FY08, on the back of strong growth in Australia 25
27 QUESTIONS
5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director
5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director AGENDA About Ramsay Health Care The Reason for Ramsay s Success December 07 Half Year Results
More informationAcquisition of Capio UK 7 September 2007 Managing Director, Pat Grier
Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier AGENDA 2 Executive Summary Why the UK Hospital Sector? Capio UK Business Overview Transaction Overview Financials Compelling Proposition
More informationRamsay Health Care Christopher Rex, Managing Director. Australia and New Zealand 7th Annual Investment Conference London 9 March, 2010
Ramsay Health Care Christopher Rex, Managing Director Australia and New Zealand 7th Annual Investment Conference London 9 March, 2010 DISCLAIMER This Presentation has been prepared by Ramsay Health Care
More informationRamsay Health Care Macquarie Australia Conference 2 May Christopher Rex, Managing Director
Ramsay Health Care Macquarie Australia Conference 2 May 2013 Christopher Rex, Managing Director AGENDA 1. Ramsay Health Care Overview 2. Growth Story & Formula for Success 3. Half-year Group Operational
More information8 th Annual Australian & New Zealand Investment Conference London 8 March Christopher Rex, Managing Director
8 th Annual Australian & New Zealand Investment Conference London 8 March 2011 Christopher Rex, Managing Director AGENDA About Ramsay Health Care Growth Story Formula For Success Recap Half-Year Results
More informationRAMSAY HEALTH CARE LIMITED ABN APPENDIX 4D FOR THE HALF YEAR ENDED 31 DECEMBER 2007
RAMSAY HEALTH CARE LIMITED ABN 57 001 288 768 APPENDIX 4D FOR THE HALF YEAR ENDED 31 DECEMBER 2007 RAMSAY HEALTH CARE LIMITED INDEX 1. 1.1 1.2 Results for Announcement to the Market Highlights of Results
More informationFor personal use only
Ramsay Health Care Limited MACQUARIE SECURITIES AUSTRALIA CONFERENCE 2015 6 May 2015 Christopher Rex, Managing Director AGENDA 1. Ramsay Health Care Overview 2. Group Financial Highlights for the six months
More informationRAMSAY HEALTH CARE REPORTS 23.6% RISE IN FULL YEAR CORE NET PROFIT
ASX ANNOUNCEMENT 25 August 2011 RAMSAY HEALTH CARE REPORTS 23.6% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 after tax up 23.6% to $220.6 million Core EPS 2 up 19.6% to 101.1
More informationRAMSAY HEALTH CARE LIMITED ABN APPENDIX 4E
RAMSAY HEALTH CARE LIMITED ABN 57 001 288 768 APPENDIX 4E RAMSAY HEALTH CARE LIMITED INDEX 1. 1.1 1.2 Results for Announcement to the Market Highlights of Results Commentary on Results 2. Financial Information
More informationRamsay Health Care Deutsche Bank Australia Corporate Day London 12 March 2013
Ramsay Health Care Deutsche Bank Australia Corporate Day London 12 March 2013 Christopher Rex, Managing Director Bruce Soden, Chief Financial Officer AGENDA 1. Ramsay Health Care Overview 2. Growth Story
More informationFor personal use only
ASX ANNOUNCEMENT 23 August 2012 RAMSAY HEALTH CARE REPORTS 14.5% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 up 14.5% to $252.6 million Reported statutory net profit after
More informationMacquarie Connections 12 th Annual Australia Conference 5 May Christopher Rex, Managing Director
Macquarie Connections 12 th Annual Australia Conference 5 May 2011 Christopher Rex, Managing Director AGENDA About Ramsay Health Care Growth Story Formula For Success Recap Half-Year Results Operating
More informationBriefing 25 February 2010 Financial Results Half Year ended 31 December 2009 Christopher Rex, Managing Director
Briefing 25 February 2010 Financial Results Half Year ended 31 December 2009 Christopher Rex, Managing Director AGENDA Half-year overview Group financial performance Financial performance Australia & Indonesia,
More informationThe Independent Hospital Sector. Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008
The Independent Hospital Sector Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008 1 Agenda Overview of Ramsay Health Care The Independent Hospital Sector UK Market
More informationRAMSAY HEALTH CARE LIMITED Annual General Meeting 20 November 2001
Annual General Meeting 20 November 2001 Chairman s Overview! Strong year of growth in Australian private hospital sector! Operating environment conducive to further growth for Ramsay! Ramsay reports record
More informationThe acquisition is expected to be neutral to mildly accretive to Core EPS in FY 2006 and accretive to Core EPS in FY 2007 and beyond.
14 April 2005 RAMSAY HEALTH CARE ACQUIRES AFFINITY HEALTH Ramsay Health Care Limited ( Ramsay ) (ASX: RHC) has today acquired Affinity Healthcare Limited ( Affinity ), for a total purchase price of approximately
More informationRAMSAY HEALTH CARE LIMITED ABN APPENDIX 4D
RAMSAY HEALTH CARE LIMITED ABN 57 001 288 768 APPENDIX 4D FOR THE HALF YEAR ENDED 31 DECEMBER 2010 RAMSAY HEALTH CARE LIMITED INDEX 1. 1.1 1.2 Results for Announcement to the Market Highlights of Results
More informationH1 16 interim results. 22 September 2015
H1 16 interim results 22 September 2015 Important notice 2 This presentation may include certain forward-looking statements, beliefs or opinions, including statements with respect to the Company s business,
More informationColin Goldschmidt. Chief Executive Officer
Annual General Meeting 19 November 2009 Colin Goldschmidt Chief Executive Officer FY 2009 Highlights Record financial result Sonic outperforms guidance Business resilience in face of global financial crisis
More informationInterim report January September 2017
Capio AB (publ) Interim report January September 2017 July September 2017 Net sales MSEK 3,455 (3,168). Organic sales growth 2.2% (2.6) and total sales growth 9.1% (3.7) EBITDA 1 MSEK 168 (200) and margin
More informationFull Year Results to 31 January 2018 Announced 22 March 2018
Sigma Healthcare Limited Full Year Results to 31 January 2018 Announced 22 March 2018 ASX Ticker: SIG Important Notice The material provided is a presentation of general information about Sigma s activities
More informationFY19 half year results
FY19 half year results For the six months ended 31 December 2018 14 February 2019 Gordon Ballantyne Managing Director & Chief Executive Officer Michael Sammells Chief Financial Officer 1 1HFY19 returned
More informationFor personal use only
Affinity Education Group (ASX:AFJ) Morgans Conference 10 October 2014 Disclaimer This presentation contains general information in summary form which is current as at 10 October 2014. It presents financial
More informationMEDIA RELEASE 22 August 2002
MEDIA RELEASE 22 August 2002 FINANCIAL RESULTS FOR THE YEAR ENDED 30 JUNE 2002 HIGHLIGHTS Revenue of $860M representing an increase of 36.9% over the previous period, flowing from acquisitions and continued
More informationRamsay Health Care (RHC AU) RHC UK on the mend?
17 October 2018 Australia EQUITIES RHC AU Price (at 05:48, 17 Oct 2018 GMT) Outperform A$54.18 Valuation A$ 68.50 - DCF (WACC 7.4%, beta 0.9, ERP 5.0%, RFR 3.7%, TGR 3.7%) 12-month target A$ 68.50 12-month
More informationFor personal use only. JB Hi-Fi Limited. HY17 Results Presentation
JB Hi-Fi Limited HY7 Results Presentation 3 5 FEBRUARY AUGUST 06 07 PAGE Agenda. Group Performance Overview. JB HI-FI 3. The Good Guys 4. Stores 5. Group Balance Sheet and Cash Flow 6. Outlook Richard
More informationGenesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015
Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare
More informationFor personal use only
Preliminary Final Report Appendix 4E Results for announcement to the market Pulse Health Limited (ACN 104 113 760) This Preliminary Final Report is provided to the Australian Securities Exchange (ASX)
More informationFor personal use only
FY16 FULL YEAR RESULTS REVIEW Agenda GROUP RESULTS OVERVIEW BUSINESS UNIT REVIEW OUTLOOK Eastlands Shopping Centre BSA completed the mechanical services upgrade and extension to one 29/08/2016 BSA Limited
More informationBank of Queensland. Full Year Results 31 August 2008
Bank of Queensland Full Year Results 31 August 2008 Agenda Result highlights David Liddy Managing Director & CEO Financial result in detail Ram Kangatharan Group Executive & CFO BOQ Portfolio Ram Kangatharan
More informationQ3 trading update. 30 October 2017
Q3 trading update 2017 30 October 2017 Business highlights Q3 2017 Signs of a stabilising oil and gas environment Revenue and results in building & infrastructure market segment increased; other markets
More informationInterim FY 2015 results 6 months ended 31 December February 2015
Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationNorthgate plc. Return to growth. Preliminary results Year ended 30 April June Northgate plc
Northgate plc Return to growth Interim results for the six months ended 31 October 2013 Northgate plc Preliminary results Year ended 30 April 2013 June 2013 Agenda Financial review Operational review UK
More informationFY2015 Annual Results August Brett McKeon - CEO David Bailey - CFO
FY2015 Annual Results August 27 2015 Brett McKeon - CEO David Bailey - CFO FY2015 Financial Results Highlights Delivery on FY15 Prospectus forecasts Pro forma NPAT $19.3 million up 8.4% against IPO forecast
More informationBank of Queensland. Half-Year Results 29 February FY08 Half-Year Results
Bank of Queensland Half-Year Results 29 February 2008 1 Agenda Result highlights Financial result in detail BOQ Portfolio Strategy and outlook David Liddy Managing Director & CEO Ram Kangatharan Group
More information(Registration no C) (Registration no C) Financial Results. (unaudited) 11 November 2009
3 rd Quarter and 9-Month 9 2009 Financial Results (unaudited) 11 November 2009 1 Important note on forward looking statements The presentation herein may contain forward looking statements by the management
More informationFor personal use only
G8 Education 2015 Results Presentation G8 Education Limited (ASX:GEM) 22 February 2016 Corporate Snapshot Key Financial Highlights CY15 Capital Structure Underlying EBIT $145.4m Fully Paid Ordinary Shares
More informationEarnings Presentation 4th Quarter, 2017
Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More information1H14 HIGHLIGHTS. EBITDA of $165.6m, 19% increase on 1H13 (excl one-off items*). NPAT and EPS up 15% vs 1H13.
-1- 1H14 HIGHLIGHTS EBITDA of $165.6m, 19% increase on 1H13 (excl one-off items*). NPAT and EPS up 15% vs 1H13. Consumer division EBITDA up 17% vs 1H13 (excl one-off items*), driven by organic broadband
More informationSOUTHERN CROSS AUSTEREO
SOUTHERN CROSS AUSTEREO H1 FY15 INVESTOR PRESENTATION 25 FEBRUARY 2015 DISCLAIMER Summary information The material in this presentation has been prepared by Southern Cross Media Group Limited ABN 91 116
More informationRevenue $m 1, , % 1, , % EBITDA $m (12%) NPAT $m (11%)
1H18 SUMMARY RESULTS Reported Underlying (1) 1H18 1H17 Growth 1H18 1H17 Growth Revenue $m 1,252.0 1,241.8 1% 1,252.0 1,234.8 1% EBITDA $m 418.2 473.4 (12%) 418.2 417.6 - NPAT $m 198.7 224.0 (11%) 217.7
More informationDr Colin Goldschmidt. CEO, Sonic Healthcare
HlfY Half Year Results For the period ending 31 December, 2008 Dr Colin Goldschmidt CEO, Sonic Healthcare 24 February 2009 Highlights Record results for hlf half year period Strong organic revenue growth
More information2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer
2011 Interim Results Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer Emeco 2011 Interim Results Overview Financials Strategy & Outlook Questions Appendices
More informationHalf Year Results to 31 July 2018 Announced 6 September 2018
Sigma Healthcare Limited Half Year Results to 31 July 2018 Announced 6 September 2018 ASX Ticker: SIG Important Notice The material provided is a presentation of general information about Sigma s activities,
More informationHalf year results 30 September 2017
Half year results 30 September November Russell Down, Chief Executive Chris Morgan, Group Finance Director Strong first half performance Revenue (excluding disposals) 183.2m 6.9% HY17: 171.4m EBITDA* 33.8m
More information1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer
1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer 21 August 2018 Important Notice and Disclaimer This presentation has been prepared by Asaleo Care
More informationNKT Holding. Interim Report Q Audiocast presentation 8 November 2012 at 10:00 am CET
NKT Holding Interim Report Q3 2012 Audiocast presentation 8 November 2012 at 10:00 am CET Agenda Page Page 2 2 NKT Group Highlights Q3 2012 Financial results Q3 2012 Companies NKT Cables Nilfisk-Advance
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationFor personal use only 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R
1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R 2 0 1 5 17 FEBRUARY 2016 OVERVIEW 1H 2016 Underlying result in line with expectations Reported results strong supported by one-offs Strengthened
More informationFull Year Results Presentation
Full Year Results Presentation 12 months ended 31 December 2010 8 March 2011 1 Agenda 1. Introduction and Highlights Ray King, Chief Executive 2. Financial Review Tom Singer, Group Finance Director 2.1
More informationAUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016 AGENDA 2 1 Opening remarks / market update 2 Financial results 3 Operational review 4 Strategy update 5 Outlook 1 2 3 4 5 OPENING REMARKS / MARKET UPDATE
More information2017 Half-year results presentation. Andrew Rashbass and Colin Jones 18 May 2017
2017 Half-year results presentation Andrew Rashbass and Colin Jones 18 May 2017 Context Investor Day in March 2016 Flagged 2017 as a year of transition DMGT sell-down an accelerator of the strategy Page
More informationFY12 Results 22 May 2012
FY12 Results 22 May 2012 DISCLAIMER --- Important Notice This presentation has been prepared by Thorn Group Limited (Thorn). This presentation is not a financial product or investment advice or recommendation,
More informationENIRO Q1 REPORT Johan Lindgren, CEO Mattias Lundqvist, CFO Cecilia Lannebo, Head of IR
ENIRO Q1 REPORT 2012-04-25 Johan Lindgren, CEO Mattias Lundqvist, CFO Cecilia Lannebo, Head of IR FINANCIAL HIGHLIGHTS, Q1 2012 Revenues SEK 959 M (966), a decline of 0,7% (-24). Organically revenues declined
More informationOneVue Holdings Limited (OVH)
OneVue Holdings Limited (OVH) H1 FY 2018 results presentation 26 February 2018 1 HIGHLIGHTS 2 FINANCIALS 3 OUTLOOK 4 APPENDICES Page 2 1 HIGHLIGHTS . BENEFITTING FROM SECTORAL GROWTH AND STRUCTURAL DISRUPTION
More informationPMP LIMITED. For personal use only INVESTOR PRESENTATION. Results for the 6 months ended 31 December February 2016
PMP LIMITED ABN 39 050 148 644 Results for the 6 months ended 31 December 2015 22 February 2016 Peter George, CEO Geoff Stephenson, CFO INVESTOR PRESENTATION 2016 HALF YEAR RESULTS Contents Pages H1 FY16
More informationKATHMANDU FY10 RESULTS PRESENTATION
KATHMANDU FY10 RESULTS PRESENTATION 1 CONTENTS Results Overview Key Line Items Country Results Cash Flow, Dividend, Balance Sheet FY11 Outlook Growth Strategy Update Questions 2 RESULTS OVERVIEW 3 RESULTS
More information2018 HALF YEAR RESULTS
2018 HALF YEAR RESULTS INVESTOR PRESENTATION 27 AUGUST 2018 DISCLAIMER The material in this presentation has been prepared by G8 Education Limited (G8) and is general background information about G8 s
More informationHalf Year FY 2015 Results Presentation FEBRUARY 2015
Half Year FY 2015 Results Presentation FEBRUARY 2015 25/02/2015 v1.3 HALF YEAR FY 2015 FINANCIAL RESULTS Revenue of $13.5m, up 65% over the prior corresponding period. EBITDA of $1.6m, up 282% over the
More information2009 Half Year Results. Analyst and shareholder briefing 18 February 2009
2009 Half Year Results Analyst and shareholder briefing 18 February 2009 Agenda Group highlights David Deverall Financial results Roger Burrows Outlook David Deverall 1 Agenda Group highlights David Deverall
More informationJohnson Controls background and Financial guidance (as announced on December 2, 2014)
If you can read this Click on the icon to choose a picture or Reset the slide. To Reset: Right click on the slide thumbnail and select reset slide or choose the Reset button on the Home ribbon (next to
More informationHalf Year Results Presentation
Half Year Results Presentation Six months ended 30 June 2010 11 August 2010 1 Agenda 1. Introduction and Highlights Ray King, Chief Executive 2. Financial Review Tom Singer, Group Finance Director 2.1
More informationING ANZ Joint Venture. Market Briefing 4 December 2002
ING ANZ Joint Venture Market Briefing 4 December 2002 Agenda Elmer Funke Kupper Introduction Environment John Wylie Integration Flows Peter Marriott Financials Elmer Funke Kupper Leveraging ANZ s planner
More informationNINE ENTERTAINMENT CO. H1 FY19 RESULTS
NINE ENTERTAINMENT CO. H1 FY19 RESULTS 21 February 2019: Nine Entertainment Co. (ASX: NEC) has released its H1 FY19 results for the six months to December 2018. On a Statutory basis, Nine reported a Net
More informationFor personal use only
Macquarie Conference Presentation 8 May 2015 Geoff Horth, CEO Presentation Content Organic Growth Driving Results Acquisition of Call Plus Group Outlook 2 Organic Growth! Driving Results! The Numbers Financial
More informationRAMSAY HEALTH CARE LIMITED ABN APPENDIX 4E FOR THE YEAR ENDED 30 JUNE 2018
RAMSAY HEALTH CARE LIMITED ABN 57 001 288 768 APPENDIX 4E RAMSAY HEALTH CARE LIMITED INDEX 1 Results for Announcement to the Market 1.1 Highlights of Results 1.2 Earnings per Share 1.3 Dividend Information
More informationFoxtons Interim results presentation For the period ended 30 June 2018
Foxtons Interim results presentation For the period ended 30 June 2018 Important information This presentation includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking
More information2018 Interim Results 30 August 2018
2018 Interim Results 30 August 2018 Disclaimer Statements in this presentation with respect to each of Total Produce s and Dole Food Company's ("Dole") business, strategies, projected financial figures,
More information27 July 2018 Interim Results
27 July 2018 Interim Results for the half year ended 30 June 2018 Disclaimer This presentation may contain forward-looking statements, including forward-looking statements within the meaning of the United
More informationANNOUNCEMENT OF PRELIMINARY RESULTS
The leading high service distributor to engineers worldwide ANNOUNCEMENT OF PRELIMINARY RESULTS YEAR ENDED 31 MARCH 2009 29 May 2009 Agenda Overview and current trading Ian Mason Financial performance
More informationBusiness Update. USPP Conference Miami. Luis Damasceno Group CFO Michael Williams Group Finance Director & Treasurer January 2019
Business Update USPP Conference Miami Luis Damasceno Group CFO Michael Williams Group Finance Director & Treasurer 23-25 January 2019 www.alsglobal.com IMPORTANT NOTICE AND DISCLAIMER This presentation
More informationNorthgate plc. Return to growth. Preliminary results Year ended 30 April June Northgate plc
Northgate plc Return to growth Preliminary results for the year ended 30 April 2014 Northgate plc Preliminary results Year ended 30 April 2013 June 2013 Agenda Group summary Financial review Depreciation
More informationOVERVIEW 1H17 RESULTS
CLICK 1H 2017 TO EDIT RESULTS MASTER TITLE 6 MONTHS ENDED 31 STYLE DECEMBER 2016 OVERVIEW 2 FINANCIAL SUMMARY Group Underlying Reported 1H 2017 1H 2016 1H 2017 1H 2016 Revenue 808.7 794.3 808.7 814.1 EBIT
More informationFor personal use only
(ASX: CGR) FY 16 Investor Presentation Daniel Riley CEO August 2016 Executive Summary FY 16 Highlights Finance Division EBITDA up 440% to $5.4m Loan Book up 325% to $69.9m Y/E 30 Jun ($m) FY 15 A FY 16
More informationFor personal use only
FY15 FULL YEAR RESULTS REVIEW Progressing to plan Agenda GROUP RESULTS OVERVIEW BUSINESS UNIT REVIEW OUTLOOK 150 Collins Street, Westpac Building. Mechanical work was completed by Allstaff Airconditioning
More informationInterim Results for the period ending 30 th September 2015
Interim Results for the period ending 30 th September 2015 10 th Nov 2015 Russell Down, Chief Executive Overview Challenging and disappointing start to the year Review identified: Poor execution of business
More informationPhoto by James Ball - Coffey International Limited FY2013 Half Year Results Presentation. 11 February 2013
Photo by James Ball - www.dlscape.com Coffey International Limited FY2013 Half Year Results Presentation 11 February 2013 Agenda Financial Performance Business Performance Outlook Presenters John Douglas
More informationRamsay Health Care Limited ACQUISITION OF CAPIO Creating a leading provider of healthcare services in Europe
Ramsay Health Care Limited ACQUISITION OF CAPIO Creating a leading provider of healthcare services in Europe Craig McNally, Chief Executive Officer, Ramsay Health Care Pascal Roché, Chief Executive Officer,
More informationFY 2015 Results Presentation. 19 January 2016
FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.
More informationRESULTS PRESENTATION. Agenda. 1. Overview Rob Sindel Managing Director, CSR Limited. 2. Financial Results David Fallu CFO, CSR Limited
RESULTS PRESENTATION Half year ended 30 September 2017 1 Agenda 1. Overview Rob Sindel Managing Director, CSR Limited 2. Financial Results David Fallu CFO, CSR Limited 3. Business Unit Performance Rob
More informationFoxtons Preliminary results presentation For the year ended December 2018
Foxtons Preliminary results presentation For the year ended December 2018 Important information This presentation includes statements that are, or may be deemed to be, forward-looking statements. These
More informationFor personal use only. F Y R e s u l t s P r e s e n t a t i o n
F Y 2 0 1 6 R e s u l t s P r e s e n t a t i o n Our Brands 2 Disclaimer The material in this presentation has been prepared by Bapcor Limited ( Bapcor ) ABN 80 153 199 912 and is general background information
More informationACQUISITION OF FASTMATCH
ACQUISITION OF FASTMATCH Expanding into a new asset class with the acquisition of a high-growth disruptive player in the FX marketplace 23 May, 2017 KEY HIGHLIGHTS OF THE TRANSACTION Transaction Overview
More informationFor personal use only. JB Hi-Fi Limited. HY18 Results Presentation
JB Hi-Fi Limited HY8 Results Presentation 5 FEBRUARY AUGUST 06 08 PAGE Agenda. Group Performance Overview. JB HI-FI 3. The Good Guys 4. Group Balance Sheet and Cash Flow 5. Outlook Richard Murray Group
More information2017 Preliminary Results. 1 March 2018
1 March 2018 Forward-Looking Statement Any forward-looking statements made in this presentation have been made in good faith based on the information available as of the date of this presentation and are
More information2018 Half Year Results Presentation. 18 September 2018
2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including
More information1H12 Results Investor Presentation
1H12 Results Investor Presentation 27 February 2012 SFG Australia Limited is a company listed on the Australian Securities Exchange; ASX Code SFW. It was formerly known as Snowball Group Limited. Important
More informationFull year report January December 2017
Full year report January December 2017 Telephone conference February 7, 2018 Thomas Berglund, CEO Olof Bengtsson, CFO Solid Q4 now speeding up the journey of specialization and digitalization Highlights
More informationAnnual General Meeting 25 November Dr Colin Goldschmidt Managing Director
Annual General Meeting 25 November 2004 Dr Colin Goldschmidt Managing Director Sonic Healthcare Current Status Company in excellent shape Record financial results FY 2004 On target to achieve FY 2005 guidance
More information1H12 EBITDA of $131.9m, 17% growth on 1H11. 65% increase in NPAT. EBITDA growth continues across both Consumer & Corporate.
1H12 Highlights 1H12 EBITDA of $131.9m, 17% growth on 1H11. 65% increase in NPAT. EBITDA growth continues across both Consumer & Corporate. Net organic broadband subscriber growth of 19k (26k On Net).
More informationYEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director
YEAR END RESULTS 31 MARCH 2018 Russell Down, Chief Executive Chris Morgan, Group Finance Director Customer service strategy improving performance Revenue (excluding disposals) 371.6m 6.4% FY17: 349.1m
More informationDMX Capital Partners Limited August 2017 Shareholder Update
DMX Capital Partners August 2017 Shareholder Update An investment company managed by: DMX Asset Management ACN 169 381 908 AFSL 459 120 Level 4, 92 Pitt Street, Sydney, NSW 2000 PO Box 916, Milsons Point,
More informationDATATEC GROUP UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016
Technology Distribution Integration & Managed Services Consulting & Research UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016 AGENDA Results summary, market conditions & operational strategy
More information2017 FULL YEAR RESULTS PRESENTATION
2017 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which
More informationSigma Pharmaceuticals Limited
Investor Relations Contact: Gary Woodford Corporate Affairs Manager Gary.Woodford@signet.com.au Phone: 03 9215 9632 Mobile: 0417 399 204 Mark Hooper CEO and Managing Director Gary Woodford Corporate Affairs
More informationInterim Results 2004 Presentation. 26 February 2004
Interim Results 2004 Presentation 26 February 2004 1 Market Overview and Financial Results Tom Honan Chief Financial Officer 2 Summary of Results Net operating profit after tax (excluding outside equity
More informationRESULTS PRESENTATION. Half year ended 30 September 2018
RESULTS PRESENTATION Half year ended 30 September 2018 Agenda Details 1. Overview Rob Sindel, Managing Director, CSR Limited 2. Financial Results David Fallu, Chief Financial Officer, CSR Limited 3. Business
More informationHalf Year Results. for the six months ended 30 November January Chairman Chris Stone CEO Adam Palser CFO Brian Tenner
Half Year Results for the six months ended 30 November 2017 16 January 2018 Chairman Chris Stone CEO Adam Palser CFO Brian Tenner Agenda Overview and strategy update Financial highlights Financial performance
More informationAsiakastieto Group Plc, appendix to the Stock Exchange Release 5 May 2015, 4.00 p.m. EET
Historical information 1.1. 31.12.2014 of Asiakastieto Group 1 (6) Asiakastieto Group Plc, appendix to the Stock Exchange Release 5 May 2015, 4.00 p.m. EET HISTORICAL FINANCIAL INFORMATION 1.1. - 31.12.2014
More information